Stay updated on Postmenopausal Breast Cancer ARV-471 vs Anastrozole Clinical Trial

Sign up to get notified when there's something new on the Postmenopausal Breast Cancer ARV-471 vs Anastrozole Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Postmenopausal Breast Cancer ARV-471 vs Anastrozole Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The study record for the ARV-471 or anastrozole breast cancer trial is displayed, including its eligibility criteria, treatment arms, outcomes, locations, and posted results. It also includes study documents such as the protocol and statistical analysis plan.
    Difference
    71%
    Check dated 2026-11-08T15:45:24.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The site revision label changed from v3.7.2 to v3.8.0. The study record remains inaccessible behind a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T16:30:54.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH terminology changes, including a transition from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-25T15:49:33.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-18T20:42:20.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The site revision identifier in the footer changed from v3.7.0 to v3.7.1; the page otherwise remains a 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T20:47:24.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, blocking access to the study record and its content. The visible page reflects an access-denied state rather than displaying the study details.
    Difference
    18%
    Check dated 2026-09-20T20:07:45.000Z thumbnail image

Stay in the know with updates to Postmenopausal Breast Cancer ARV-471 vs Anastrozole Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Postmenopausal Breast Cancer ARV-471 vs Anastrozole Clinical Trial page.